Jason Groves - MEDIFAST INC President

MED Stock  USD 14.36  0.38  2.72%   

President

Mr. Jason L. Groves Esq., serves as Executive Vice President, General Counsel, Secretary of the Company. He has served as the Companys Executive Vice President and General Counsel since November 2011, and Corporationrationrate Secretary since June 2015. Mr. Groves was also a director of the Company from 2009 to 2015 and served as a member of the Audit Committee from 2009 to 2011 and the Executive Committee from 2011 to 2015. Prior to joining Medifast in November 2011, Mr. Groves served as Assistant Vice President of Government Affairs for Verizon Maryland from 2003 until 2011 and in various other roles since he joined Verizon Maryland in 2001. Mr. Groves is also a United States Army veteran. He was a direct commissioned Judge Advocate in the United States Army Judge Advocate Generals Corporationration As a JAG Officer, he practiced law and had the distinction of prosecuting criminal cases in the District Court of Maryland as a Special Assistant United States Attorney. Over the course of three years, he received two Army Achievement Medals, and one Army Commendation Medal. Mr. Groves also sits on several nonprofit boards including the Center Club of Baltimore and chairing his law school alma mater board of visitors. He recently completed nine years with the Anne Arundel Medical Center Board of Trustees since 2015.
Age 49
Tenure 10 years
Address 100 International Drive, Baltimore, MD, United States, 21202
Phone410 581 8042
Webhttps://medifastinc.com
Groves received his BS degree, cum laude, in Hospitality Management from BethuneCookman University. He also obtained his juris doctorate from North Carolina Central University School of Law and is a member of the New Jersey and District of Columbia bars as well as several bar associations.

MEDIFAST INC Management Efficiency

The company has Return on Asset of 0.0324 % which means that on every $100 spent on assets, it made $0.0324 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0102 %, implying that it generated $0.0102 on every 100 dollars invested. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. As of March 2, 2025, Return On Tangible Assets is expected to decline to 0.01. In addition to that, Return On Capital Employed is expected to decline to 0.01. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 10.2 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 2.4 M.
MEDIFAST INC has 16.12 M in debt with debt to equity (D/E) ratio of 0.43, which is OK given its current industry classification. MEDIFAST INC has a current ratio of 1.26, demonstrating that it may not be capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for MEDIFAST to invest in growth at high rates of return.

Similar Executives

Showing other executives

PRESIDENT Age

Paul ElliottCarriage Services
64
Julie BimmermanRollins
57
Viki BlindermanCarriage Services
50
Tammy MooreService International
58
Steven JDCarriage Services
47
Elisabeth NashService International
63
Carl BrinkCarriage Services
39
Elizabeth ChandlerRollins
60
Paul NorthenRollins
55
Mary TocioBright Horizons Family
72
Ben BartlettInteractive Strength Common
N/A
Kellie LogerwellHR Block
55
Steven TidwellService International
62
Carlos QuezadaCarriage Services
54
Steven MetzgerCarriage Services
45
Jerry GahlhoffRollins
51
Karen OroscoHR Block
53
John FaulkService International
49
Eric TanzbergerService International
55
Sumner WaringService International
52
Patrick ChrzanowskiRollins
N/A
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people. MEDIFAST INC (MED) is traded on New York Stock Exchange in USA. It is located in 100 International Drive, Baltimore, MD, United States, 21202 and employs 504 people. MEDIFAST INC is listed under Personal Care Products category by Fama And French industry classification.

Management Performance

MEDIFAST INC Leadership Team

Elected by the shareholders, the MEDIFAST INC's board of directors comprises two types of representatives: MEDIFAST INC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MEDIFAST. The board's role is to monitor MEDIFAST INC's management team and ensure that shareholders' interests are well served. MEDIFAST INC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MEDIFAST INC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael MacDonald, Chairman, CEO and Chairman of Executive Committee
Jonathan Mackenzie, Chief Accounting Officer
Ming Xian, Independent Director
Anthony Tyree, Chief Marketing Officer
Michael Hoer, Independent Director
Daniel Chard, Executive Chairman of the Board, Chief Executive Officer
James CPA, Chief Officer
Jeffrey Brown, Lead Independent Director
William Baker, Executive Vice President Information Technology
Stephen Johnson, Chief Accounting Officer, Vice President - Finance
Andrea Thomas, Independent Director
Lauren Walker, Executive Vice President - Supply Chain Operations
Jason Esq, General VP
Jason Groves, Executive Vice President, General Counsel, Corporate Secretary
Steven Zenker, Vice Relations
Joseph Kelleman, Interim Chief Financial Officer, Vice President - Finance
Scott Schlackman, Independent Director
James Maloney, Chief Financial Officer, Interim Principal Accounting Officer
Kevin Byrnes, Independent Director
Carl Sassano, Independent Director
Constance Hallquist, Independent Director
Nicholas Johnson, Executive Vice President - Coach Success, Market President of OPTAVIA USA
Claudia Greninger, Executive Vice President - Human Resources

MEDIFAST Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MEDIFAST INC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.87)
Earnings Share
0.19
Revenue Per Share
55.12
Quarterly Revenue Growth
(0.38)
Return On Assets
0.0324
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.